DIVA Laboratories, Ltd. (TPEX:4153)
42.10
-0.15 (-0.36%)
Apr 24, 2025, 1:30 PM CST
DIVA Laboratories Revenue
In the year 2024, DIVA Laboratories had annual revenue of 862.32M TWD, down -3.53%. DIVA Laboratories had revenue of 223.27M in the quarter ending December 31, 2024, with 8.98% growth.
Revenue
862.32M
Revenue Growth
-3.53%
P/S Ratio
2.86
Revenue / Employee
5.60M
Employees
154
Market Cap
2.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 862.32M | -31.52M | -3.53% |
Dec 31, 2023 | 893.84M | -55.36M | -5.83% |
Dec 31, 2022 | 949.20M | 236.97M | 33.27% |
Dec 31, 2021 | 712.23M | -24.69M | -3.35% |
Dec 31, 2020 | 736.93M | 20.76M | 2.90% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.82B |
Lumosa Therapeutics | 39.15M |